Raws li kev tshawb fawb rau hauv neuroinflammation, lub endocannabinoid system, thiab lub plab - hlwb axis tob zuj zus mus, lub zej zog kev tshawb fawb tau rov qab nws txaus siab rau endogenous lipid molecules uas muaj peev xwm immunomodulatory thiab neuroprotective. Ntawm cov no,palmitoylethanolamide (PEA)tsis ntev los no tau nthuav dav nws qhov kev tshawb fawb los ntawm qhov mob thiab mob rau hauv thaj chaw ntawm neuropsychiatric noj qab haus huv; yog li ntawd, kev sib txuas ntawm PEA thiab kev nyuaj siab tau dhau los ua ib lub ntsiab lus tseem ceeb hauv kev tshawb fawb thiab kev noj qab haus huv- hais txog kev sib tham.
Txawm hais tias kev tshawb fawb tam sim no tsis tau faib PEA ua cov tshuaj tiv thaiv kev ntxhov siab tag nrho, kev tshawb pom los ntawm kev tshawb fawb tsiaj, kev tshawb fawb siv tshuab, thiab kev sim tshuaj tib neeg ua ntej qhia tias PEA tuaj yeem cuam tshuam cov txheej txheem lom neeg cuam tshuam nrog kev nyuaj siab los ntawm ntau txoj hauv kev, suav nrog PPAR- kev taw qhia, kev hloov kho ntawm neuroinflammation, endocannabinoidated{1} thiab cov teeb liab.
KINTAIBIO®yog ib lub chaw tsim khoom ntawm cov nroj tsuag extracts, muab siab -zoopalmitoylethanolamide PEA hmoovrau cov neeg siv khoom thoob ntiaj teb. Peb txais tos nug txog peb cov khoom ntawmsales@kintaibio.com.
Palmitoylethanolamide (PEA) yog dab tsi?
Palmitoylethanolamide (PEA) yog ib qho tshwm sim ntawm fatty acid ethanolamide uas muaj nyob rau ntawm N-acylethanolamine tsev neeg thiab ua hauj lwm raws li endogenous lipid mediator nyob rau hauv tib neeg lub cev. PEA yog synthesized nyob rau hauv vivo ntawm phospholipid-txog txoj kev metabolic thiab yog metabolized los ntawm enzymes xws li FAAH thiab NAAA. Cov kev tshawb fawb uas twb muaj lawm qhia tau hais tias PEA muaj cov khoom siv lom neeg xws li tshuaj tiv thaiv -inflammatory, analgesic, thiab neuroprotective teebmeem; Yog li ntawd, nws tau ntev tau ua ib qho kev txaus siab hauv thaj chaw mob, neuroinflamation, thiab kev tshawb fawb txog kev puas hlwb.
Hais txog nws mechanism ntawm kev txiav txim, ib qho ntawmPalmitoylethanolamide PEALub hom phiaj tseem ceeb tshaj plaws ntawm cov molecular yog peroxisome proliferator-activated receptor alpha (PPAR- ). Cov kev tshawb fawb tau pom tias PPAR- koom nrog cov txheej txheem xws li cov lus teb inflammatory, lipid metabolism, thiab kev tiv thaiv kab mob; raws li kev ua haujlwm los ntawm PEA, PPAR- modulates o-txog txoj kev taw qhia, suav nrog NF-κB txoj hauv kev. Tsis tas li ntawd, kev tshawb fawb tau qhia txog kev sib cuam tshuam ntawm Palmitoylethanolamide thiab GPR55, TRPV1, thiab endocannabinoid system. Yog li, PEA tsis tawm nws cov teebmeem los ntawm ib lub hom phiaj tab sis yuav tswj hwm cellular thiab cov ntaub so ntswg homeostasis los ntawm ntau txoj kev sib cuam tshuam lipid signaling.
Muaj peev xwm Mechanisms of Action of PEA in Depression
Core Mechanisms Mediated los ntawm PPAR Txoj Kev
Palmitoylethanolamide PEAyog lub ntuj agonist ntawm peroxisome proliferator -activated receptor alpha (PPAR ). Cov kev tshawb fawb tsiaj pom tau hais tias PEA siv tshuaj tiv thaiv kev nyuaj siab- zoo li los ntawm kev ua kom txoj hauv kev PPAR hauv hippocampus. PEA kuj thim rov qab cov qib txawv txav ntawm ntau yam oxidative kev nyuaj siab biomarkers thiab ua rau kom cov concentrations ntawm ob yam neurotrophic hauv hippocampus. PPAR antagonist MK886 tuaj yeem ua tiav lossis ib feem thaiv cov teebmeem no, lees paub tias txoj hauv kev PPAR yog lub hom phiaj tseem ceeb rau PEA cov tshuaj tiv thaiv kev ntxhov siab. Txoj hauv kev no yog koom nrog kev tswj hwm kev ruaj ntseg ntawm hypothalamic-pituitary-adrenal (HPA) axis, pab txhawb kev tiv thaiv antioxidant, thiab kho cov qib neurotrophic.
Kev tswj hwm ntawm Endocannabinoid System
PEA lub hom phiaj tsis yog PPAR nkaus xwb tab sis kuj G protein-coupled receptor 55 (GPR55) thiab -txawm tias nrog qis affinity-CB1/CB2 receptors, yog li koom nrog hauv kev tswj hwm ntawm endocannabinoid system. Kev tshawb fawb qhia txog kev sib raug zoo ntawm PEA qib thiab cov endocannabinoids xws li AEA hauv cov neeg mob kev nyuaj siab. Thaum Palmitoylethanolamide ncaj qha cuam tshuam nrog tryptophan hauv cov neeg asymptomatic, qhov kev sib raug zoo no ploj mus hauv cov neeg mob kev nyuaj siab; Hloov chaw, kev sib raug zoo tshwm sim ntawm PEA thiab AEA, 2-AG, thiab OEA, tawm tswv yim tiasPalmitoylethanolamide PEA hmoovtuaj yeem ua raws li kev cai tswj hwm nyiaj txiag thaum lub xeev kev nyuaj siab.
Remodeling ntawm Hippocampal Neuroplasticity
PEA remodels hippocampal circuits los ntawm kev nce cov neeg laus hippocampal neurogenesis thiab synaptic plasticity thaum txo qis neuronal apoptosis. Tshwj xeeb,Palmitoylethanolamide PEA hmoovthim rov qab qhov kev tswj hwm ntawm cov neurogenesis vim yog kev ntxhov siab ntev thiab ua kom lub cev tsis zoo ntawm cov proteins cuam tshuam nrog synaptic plasticity (xws li NCAM, MAP2, SYN, thiab PSD95). Hauv kev sim, Palmitoylethanolamide ua rau kom muaj sia nyob ntawm hippocampal neurons raug corticosterone (CORT), txo qhov kev qhia ntawm caspase-3 thiab cleaved-caspase-3, thiab nce Bcl-2/Bax piv. Cov teebmeem no tseem tuaj yeem thim rov qab ib nrab lossis tag nrho los ntawm PPAR antagonist MK886.
Kev tswj hwm ntawm Monoamine Neurotransmitters
Palmitoylethanolamide nce 5-HT theem nyob rau hauv prefrontal cortex thiab txo cov metabolic turnover ntawm dopamine thiab 5-HT nyob rau hauv lub nucleus accumbens thiab prefrontal cortex. Tsis tas li ntawd, PEA tau txuas nrog tryptophan-kynurenine metabolic txoj hauv kev-qhia kev sib raug zoo nrog tryptophan hauv cov neeg mob asymptomatic, kev sib raug zoo uas tsis muaj nyob hauv cov neeg mob uas muaj kev nyuaj siab-qhia tiasPEA Palmitoylethanolamide hmoovtuaj yeem tswj hwm 5-HT synthesis tsis ncaj los ntawm kev cuam tshuam rau tryptophan metabolic txoj hauv kev.
PEA puas muaj kev nyab xeeb? Cov teebmeem ntawm PEA yog dab tsi?
Cov kev tshawb fawb soj ntsuam uas twb muaj lawm feem ntau qhia tiasPEA hmoovzoo - zam. Kev tshawb fawb dav dav ntawm tib neeg tau tsom mus rau qhov mob, neuroinflamation, thiab lwm yam mob. Txawm hais tias ntau qhov kev sim tshuaj txhawb nqa qhov kev pom tias Palmitoylethanolamide feem ntau ua tau zoo- zam, kev hloov pauv ntawm hom kev kho mob, cov qauv, ntau npaum li cas, thiab kev kawm ntev txhais tau hais tias txuas ntxiv mus ntev - lub sij hawm, loj - cov kev tshawb fawb loj yuav tsum tau ntsuas tag nrho nws cov ntaub ntawv kev nyab xeeb. Kev tshuaj xyuas yav dhau los ntawm kws tshuaj thiab kev nyab xeeb hauv chaw kho mob tau sau tseg tias qhov tsis muaj cov cim tseem ceeb hais txog qhov tshwm sim tsis zoo nyob rau hauv luv luv -kev sim tshuaj, txawm hais tias cov ntaub ntawv ntawm kev siv sij hawm ntev - kuj tseem txwv.
Yog li ntawd, tsis yog tsuas yog hais tias "Palmitoylethanolamide tsis muaj kev phiv," nws yog qhov tseeb dua hais tias thaum kev tshawb fawb tam sim no qhia tau hais tias PEA feem ntau ua tau zoo - zam, ntxiv cov ntaub ntawv hais txog qhov ntev - lub sij hawm thiab loj - nplai kev nyab xeeb tseem yuav tsum tau. Tsis tas li ntawd, cov neeg siv khoom lossis cov neeg mob tam sim no noj cov tshuaj tiv thaiv kev ntxhov siab, tshuaj sedatives, lossis lwm yam tshuaj yuav tsum tsis txhob hloov kho lawv cov kev kho mob uas twb muaj lawm ntawm lawv tus kheej vim tsuas yogPalmitoylethanolamide hmoovyog lawm derived los yog tau pom zoo tolerability nyob rau hauv cov kev tshawb fawb.
PEA puas tuaj yeem hloov cov tshuaj tiv thaiv kev ntxhov siab?
Tam sim no, tsis muaj pov thawj kho mob txaus los ua pov thawj tiasPalmitoylethanolamide PEAtuaj yeem hloov cov tshuaj tiv thaiv kev ntxhov siab uas tau pom zoo, thiab tsis muaj pov thawj txaus los txhawb nws txoj kev siv raws li kev kho mob ib leeg rau kev nyuaj siab loj. Qhov no yog pov thawj los ntawm cov tib neeg kev sim tshuaj uas twb muaj lawm, uas qhia txog Palmitoylethanolamide lub peev xwm muaj txiaj ntsig ntau dua li nws qhov tsim nyog los hloov cov tshuaj tiv thaiv kev ntxhov siab.
Yog li ntawd, cov tib neeg uas kuaj pom tias muaj kev nyuaj siab uas tam sim no tab tom kho yuav tsum tsis txhob txiav lawv cov tshuaj lossis kho cov tshuaj ntawm lawv tus kheej. Tam sim no, PEA tau sib tham zoo tshaj plaws raws li bioactive lipid molecule nrog kev tshawb fawb muaj peev xwm.
Palmitoylethanolamide thiab Kev Nyuaj Siab: Xaus
Cov kev tshawb fawb tam sim no qhia tau tias muaj peev xwm sib txuas ntawmPalmitoylethanolamide thiab kev nyuaj siabuas lav kev tshawb nrhiav ntxiv. Cov kev tshawb fawb tsiaj thiab kev siv tshuab tau muab lub hauv paus theoretical cuam tshuam nrog neuroinflamation, PPAR- txoj hauv kev, thiab kev hloov pauv ntawm cov tshuaj neuroactive. Txawm li cas los xij, pov thawj los ntawm tib neeg kev tshawb fawb tseem txwv; muaj qhov tshwj xeeb tsis muaj qhov loj - nplai, ntev- lub sij hawm soj ntsuam kev sim nrog tus kheej validation.
Raws li ib tugpalmitoylethanolamide (PEA) hmoov chaw tsim tshuaj paus, KINTAIBIO®tsom tsis tau tsuas yog rau cov ntsiab lus ntawm cov khoom muaj nqis xwb tab sis kuj tseem nyob rau hauv batch -rau -batch stability thiab kev tswj kom zoo. Ua kom tau raws li qhov xav tau thoob ntiaj tebPalmitoylethanolamide hmoov, PEA hmoov tsum,PEA bulk hmoov, peb muab cov khoom tsim raws li cov txheej txheem thov tshwj xeeb, txhawb nqa los ntawm cov qauv tsim nyog thiab cov ntaub ntawv zoo.
Thaum lub sij hawm tsim khoom thiab kev tswj kom zoo, peb saib xyuas qhov tseem ceeb tsis zoo - suav nrog kev ua kom huv huv, lub cev muaj zog, kev txwv microbiological, thiab cov ntsiab lus hlau hnyav- thiab siv cov kev tshuaj ntsuam xyuas xws liHPLClos xyuas qhov muaj pes tsawg leeg, ua kom muaj kev ruaj ntseg thiab sib xws ntawm cov khoom siv. Peb muab cov ntaub ntawv tseem ceeb xws liCOAsthiabMSDSsthiab muab cov kev pabcuam customization kom tau raws li cov ntawv thov tshwj xeeb thiab cov kev xav tau tshwj xeeb. Thov hu rau peb ntawmsales@kintaibio.comyog xav paub ntxiv.
